<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/495823B4-6E37-442A-9BF5-3C4845C68D52"><gtr:id>495823B4-6E37-442A-9BF5-3C4845C68D52</gtr:id><gtr:firstName>Walter</gtr:firstName><gtr:surname>Kolch</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/48C13E55-28C1-4AE4-BA67-521BE128FE74"><gtr:id>48C13E55-28C1-4AE4-BA67-521BE128FE74</gtr:id><gtr:firstName>Graeme</gtr:firstName><gtr:surname>Milligan</gtr:surname><gtr:orcidId>0000-0002-6946-3519</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/599807B2-C178-45E6-8C5F-7A6617273BD5"><gtr:id>599807B2-C178-45E6-8C5F-7A6617273BD5</gtr:id><gtr:firstName>Miles</gtr:firstName><gtr:otherNames>Douglas</gtr:otherNames><gtr:surname>Houslay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/050B7749-5712-4F0B-AA25-F56D84082A9D"><gtr:id>050B7749-5712-4F0B-AA25-F56D84082A9D</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Pitt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400053"><gtr:id>B73E0874-7FED-425B-8CEE-CE407680097F</gtr:id><gtr:title>Protein interactions and compartmentalisation in cell signalling</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400053</gtr:grantReference><gtr:abstractText>At the molecular level diseases are caused by failures of cellular control systems. These control systems are organised in protein networks that generate specific biological responses through combinatorial interactions between the components. In order to understand the function of these control networks we need to identify their components and how they interact with each other. This is now possible through modern technologies such as proteomics for protein identification at high speed and sensitivity, and the microscopic imaging of protein interactions. Having successfully established these technologies we want to use them in this research project to analyse the interaction network formed by three important cellular control systems (GPCR, cAMP, ERK). These three control systems are subverted in a great variety of diseases including inflammation, cancer, infection, cardiovascular and neurological disorders. Elucidating how these control systems interact will further our understanding of the molecular changes that cause disease and is expected to lead to the identification of novel molecular targets for drugs and therapeutic intervention. Ultimately, this will lead to better therapies.</gtr:abstractText><gtr:technicalSummary>Signalling pathways are important drug targets. However, the design of selective intervention strategies is hampered by the pleiotropic functions of signalling proteins and by a lack of understanding how they integrate signals to achieve biological specificity. Here we want to investigate the role of protein interactions and compartmentalisation for the function of three important and functionally interrelated signalling systems: GPCRs, cAMP PDEs and the ERK pathways. These pathways govern fundamental biological processes that are relevant for human health, including metabolic control, differentiation, malignant transformation and inflammation. Rather than simple linear pathways these signalling systems form networks whose function and behaviour is in great part determined through the assemblies of specific protein complexes in different cellular compartments. The three signalling systems to be studied provide important drug targets and known to interact at multiple levels. We want to apply our expertise in proteomics to dissect and identify the components of the multiprotein signalling complexes that connect and distinguish aspects of these signalling systems. The overall aim is to elucidate the functional connectivities between these key signalling systems with a view to understand how protein assemblies can generate networks that define biological specificity.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>480774</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>28117</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust 'Value in People' Awards</gtr:description><gtr:end>2008-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A6C6C0EF-C865-42BF-B1B0-A3A9BCF94574</gtr:id><gtr:outcomeId>7CAC53FD7630</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fondation Leducq funding (Transatlantic Networks Of Excellence)</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Transatlantic Networks of Excellence in Cardiovascular Research Program</gtr:fundingOrg><gtr:id>F96718BC-D2C7-4FD6-9853-B8AC6553B743</gtr:id><gtr:outcomeId>1410F4369D20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BB0C57D5-7BFC-4086-A6E6-2D70198421AD</gtr:id><gtr:title>Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/771a782eab14f8ce2ca63859a833bd41"><gtr:id>771a782eab14f8ce2ca63859a833bd41</gtr:id><gtr:otherNames>Kiely PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>F2229426A4B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10DF88CE-8D4F-4B69-98FD-D454FAB71B87</gtr:id><gtr:title>Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcc2284555def528ab993e8adea04d60"><gtr:id>bcc2284555def528ab993e8adea04d60</gtr:id><gtr:otherNames>Xu TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>pm_15132_22_22025682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62EDB29A-092B-4760-9107-F9336C86C43E</gtr:id><gtr:title>Selectivity and functional consequences of interactions of family A G protein-coupled receptors with neurochondrin and periplakin.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ca60e302065b8bcff5997ea08ec5c15"><gtr:id>4ca60e302065b8bcff5997ea08ec5c15</gtr:id><gtr:otherNames>Ward RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>CE0215C7599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>878D1A63-41DB-4BA0-BD64-41A827ADA1B8</gtr:id><gtr:title>EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecf4cd9acb13c24315858961d0ffcd3d"><gtr:id>ecf4cd9acb13c24315858961d0ffcd3d</gtr:id><gtr:otherNames>Huston E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>02824D19E66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D807448-1156-44A5-BCD9-C2713B5B4A02</gtr:id><gtr:title>Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcc2284555def528ab993e8adea04d60"><gtr:id>bcc2284555def528ab993e8adea04d60</gtr:id><gtr:otherNames>Xu TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>doi_55f954954fa12bb6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13D87920-DD2C-430C-8730-D21CABCE5AC2</gtr:id><gtr:title>Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcc2284555def528ab993e8adea04d60"><gtr:id>bcc2284555def528ab993e8adea04d60</gtr:id><gtr:otherNames>Xu TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>sfbze6Nz1zY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67FDA29C-892E-4197-B09B-576FD0634CDC</gtr:id><gtr:title>MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b0457324b4db06708dfba291ef09e54"><gtr:id>9b0457324b4db06708dfba291ef09e54</gtr:id><gtr:otherNames>Meng D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>4BCE5D87D43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F29B7D5-ACC4-44EB-A1BE-F79FD3E587E1</gtr:id><gtr:title>Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcc2284555def528ab993e8adea04d60"><gtr:id>bcc2284555def528ab993e8adea04d60</gtr:id><gtr:otherNames>Xu TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>F9A8DFE0F11</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F0834C8-B8FE-43CE-B4AF-87CC4D1F18CE</gtr:id><gtr:title>Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/771a782eab14f8ce2ca63859a833bd41"><gtr:id>771a782eab14f8ce2ca63859a833bd41</gtr:id><gtr:otherNames>Kiely PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>D540ABE1B5A</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400053</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>